1-(butan-2-yl)-2-methylpiperazine
|
- $289 - $2543
- Product name: 1-(butan-2-yl)-2-methylpiperazine
- CAS: 1226016-85-8
- MF: C9H20N2
- MW: 156.27
- EINECS:
- MDL Number:MFCD16300931
- Synonyms:1-(butan-2-yl)-2-methylpiperazine;Piperazine, 2-methyl-1-(1-methylpropyl)-
5 prices
Selected condition：
Brand
- AK Scientific
- Chemenu
Package
- 100mg
- 250mg
- 1g
- 5g
- ManufacturerAK Scientific
- Product number8046DQ
- Product description1-(Butan-2-yl)-2-methylpiperazine
- Packaging100mg
- Price$289
- Updated2021-12-16
- Buy
- ManufacturerAK Scientific
- Product number8046DQ
- Product description1-(Butan-2-yl)-2-methylpiperazine
- Packaging250mg
- Price$370
- Updated2021-12-16
- Buy
- ManufacturerAK Scientific
- Product number8046DQ
- Product description1-(Butan-2-yl)-2-methylpiperazine
- Packaging1g
- Price$773
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM335529
- Product description1-(Butan-2-yl)-2-methylpiperazine 95%+
- Packaging1g
- Price$773
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM335529
- Product description1-(Butan-2-yl)-2-methylpiperazine 95%+
- Packaging5g
- Price$2543
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | 8046DQ | 1-(Butan-2-yl)-2-methylpiperazine | 100mg | $289 | 2021-12-16 | Buy |
| AK Scientific | 8046DQ | 1-(Butan-2-yl)-2-methylpiperazine | 250mg | $370 | 2021-12-16 | Buy |
| AK Scientific | 8046DQ | 1-(Butan-2-yl)-2-methylpiperazine | 1g | $773 | 2021-12-16 | Buy |
| Chemenu | CM335529 | 1-(Butan-2-yl)-2-methylpiperazine 95%+ | 1g | $773 | 2021-12-16 | Buy |
| Chemenu | CM335529 | 1-(Butan-2-yl)-2-methylpiperazine 95%+ | 5g | $2543 | 2021-12-16 | Buy |
Properties
Boiling point :195.8±8.0 °C(Predicted)
Density :0.857±0.06 g/cm3(Predicted)
pka :9.31±0.40(Predicted)
Density :0.857±0.06 g/cm3(Predicted)
pka :9.31±0.40(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|